DENVER – November 14, 2026 -- At-home ketamine therapy in Colorado skips the clinic: by the company's own timeline, medication arrives roughly 8 to 12 days after you start, and every visit happens by video. NutraBrain, a telehealth provider, treats Colorado patients through Dr. David Mahjoubi, an anesthesiologist licensed in the state, with plans from $425.
The 8-to-12-day window is our calculation from the company's figures. Most patients finish intake and consultation within 3 to 5 days, and medication typically arrives 5 to 7 days after the consultation. A licensed U.S. compounding pharmacy fills the prescription within 1 to 3 business days and ships it by signature-required courier. The company says service and prices are the same in Denver, Grand Junction, Durango, Steamboat Springs and on the Eastern Plains.
The steps: a 10-to-15-minute intake form, then a consultation of about 30 minutes with Dr. Mahjoubi. If he decides ketamine fits, he sets the format, dose and schedule. Follow-ups are also by video.
Compounded ketamine differs from the FDA-approved Spravato in regulation and supervision.
The FDA has approved ketamine as an anesthetic since 1970. Its use for depression is off label. Spravato (esketamine), a nasal spray, is the FDA-approved version for treatment-resistant depression. Its prescribing information limits it to a restricted safety program, with at least two hours of monitoring by a health care provider after each dose.
NutraBrain prescribes compounded ketamine, taken at home, and says that form is not FDA approved. Dr. Mahjoubi chooses one of five formats, including nasal spray and rapidly dissolving tablets. He is licensed in 15 states, Colorado among them, and the company says he has prescribed ketamine since 2014. He is not a psychiatrist. His stated recommendation is to see one first and keep one involved during treatment.
The annual plan costs $109 less than 12 months of Monthly Care.
- Monthly Care: $425 to start, covering the video visit and the first month's prescription, then $69 a month for ongoing care, refills, dose changes and email access.
- Pay Per Visit: $349 a visit, with a one-month prescription. The pharmacy bills medication separately.
- Annual Membership: $1,075 for the year.
By our calculation, Monthly Care comes to $1,184 over 12 months ($425 plus 11 x $69), against $1,075 for the annual plan. That is $109 less, about 9%, or roughly $90 a month. After the first prescription, the pharmacy bills Monthly Care patients directly for medication, and the company does not say what it charges. Most U.S. insurance does not cover off-label ketamine. There is no contract, and cancelling carries no fee.
A 1,247-patient study found 63% improved, but it had no placebo group.
The company cites a 2022 paper by Hull in the Journal of Affective Disorders. It was an open-label study of 1,247 adults with moderate to severe depression or anxiety treated at home through telehealth. About 63% reported depression scores improving by half or more over four weeks. Only a handful stopped because of side effects or adverse events. With no placebo group, the company says, the study cannot predict how any one person will respond. It also says ketamine does not work for everyone.
Dr. Mahjoubi decides eligibility, and several conditions rule out at-home treatment.
The company says the program may help adults with treatment-resistant depression, anxiety, PTSD, chronic pain and substance use concerns. It is not a fit for people with a history of psychosis, uncontrolled high blood pressure, a past aneurysm or bleeding in the brain, or current illicit drug use. It is also not a fit for anyone pregnant, planning a pregnancy or breastfeeding.
The company recommends having someone at home for the first session. Sessions typically run in the late afternoon or early evening. It advises no driving, no machinery and no important decisions for the rest of the day. People in crisis are directed to call or text 988.
A free qualifying quiz takes about 20 seconds, needs no email address and screens for conditions that make at-home ketamine a poor fit.